On Tuesday, Louisiana-Pacific Corporation (NYSE:LPX)’s shares inclined 0.82% to $17.16.
Louisiana-Pacific Corporation (LP) (LPX) stated results for the second quarter of 2015, which comprised of the following:
- Sales for the second quarter of $493 million were lower by 5 percent contrast to the year ago quarter.
- Net loss was $20 million ($0.14 per diluted share).
- Non-GAAP adjusted loss was $12 million ($0.08 per diluted share).
- Adjusted EBITDA for the second quarter was $16 million contrast to $26 million in the second quarter of 2014.
- Cash and cash equivalents were $481 million as of June 30, 2015.
Louisiana-Pacific Corporation, together with its auxiliaries, primarily manufactures and sells building products for use in new home construction, repair and remodeling, outdoor structures, and light industrial and commercial construction. The company’s Oriented Strand Board segment offers structural panel products comprising plywood, counting roof decking, sidewall sheathing, and floor underlayment. Its Siding segment provides SmartSide siding products and related accessories, such as wood-based sidings, trim, soffit, and fascia; and CanExel siding and accessory products, counting pre-finished lap and trim products.
Ventas, Inc. (NYSE:VTR)’s shares dropped -0.35% to $59.80.
Ventas, Inc. (VTR) declared that it has accomplished the spin-off (the “Spin-Off”) of most of its post-acute/skilled nursing facility (“SNF”) portfolio into an independent, publicly traded REIT called Care Capital Properties, Inc. (“CCP”). CCP, a pure-play SNF REIT, will primarily own, acquire and lease skilled nursing facilities operated by local and regional care providers across the United States and is listed on the New York Stock Exchange under the symbol “CCP.
Ventas anticipates to declare a dividend of at least $0.73 per share and CCP anticipates to declare a dividend of $0.57 per share ($0.1425 per share on a pre 1:4 adjustment basis). This is compriseent with Ventas’s previous expectation that the companies’ combined dividend would enhance at least 10 percent from its current level of $0.79 on an aggregate basis following the Spin-Off. In each case the predictable dividend enhance will be effective for the third quarter 2015, subject to approval by each respective Board of Directors. Ventas’s 10 year dividend compound annual growth rate is 9 percent.
Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, administration, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. The firm primarily invests in healthcare-related facilities counting hospitals, skilled nursing facilities, senior housing facilities, medical office buildings, and other healthcare related facilities. Ventas, Inc. was founded in 1983 and is based in Chicago, Illinois with additional offices in Irvine, California; Louisville, Kentucky; Charlotte, North Carolina; and Dallas, Texas.
At the end of Tuesday’s trade, Platform Specialty Products Corp (NYSE:PAH)‘s shares dipped -0.92% to $20.53.
Platform Specialty Products Corporation (PAH) a global, diversified specialty chemicals company, declared its financial results for the three and six months ended June 30, 2015.
For the three months ended June 30, 2015:
- Net sales for the second quarter 2015 were $675 million, an enhance of 257% contrast to $189 million in the second quarter of 2014.
- Performance Applications segment: Sales were $182 million, a decline of 4.0% from $189 million in the second quarter of 2014. On a constant currency basis, sales for this segment grew 4.5%.
- Agricultural Solutions segment: Sales were $494 million, a 17.2% decline from $596 million of pro forma as adjusted sales in the second quarter of 2014. On a constant currency basis, pro forma as adjusted sales grew 1.9%.
- Total constant currency sales for the quarter were $690 million, an enhance of 2.5% from second quarter 2014 pro forma constant currency sales of $672 million.
- Adjusted EBITDA for the second quarter 2015 was $168 million, an enhance of 248% contrast to $48 million from the year-preceding period.
Platform Specialty Products Corporation produces and sells specialty chemical products in the Americas, Asia, and Europe. The company’s Performance Materials segment manufactures and markets plating products that are used to plate holes; final finishes, which are used on printed circuit boards; circuit formation products to promote adhesion and form circuit patterns; oxides that are used in the fabrication of multilayer circuit boards; and pre-treatment and cleaning solutions.
CVS Health Corp (NYSE:CVS), ended its Tuesday’s trading session with -0.26% loss, and closed at $108.46.
CVS Health Corporation (CVS) declared that it has accomplished the acquisition of Omnicare, the leading provider of pharmacy services to long term care facilities, for a total enterprise value of about $12.9 billion.
CVS Health Corporation, together with its auxiliaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit administration services, such as plan design and administration, formulary administration, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network administration services, prescription administration systems, clinical services, disease administration programs, and medical pharmacy administration services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
